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1. Introduction 
Encephalitis may result from the interaction between a pathogen and the host brain, such as 
in bacterial, viral or fungal infection of the CNS. There are, however, different states of 
aseptic encephalitis, which may be induced e.g. by way of (i) self-directed immune attacks 
as in experimental autoimmune encephalomyelitis or (ii) by certain substances like the 
copper chelating agent cuprizone (Torkildsen et al., 2008).  
In fact, in encephalitis, infectious and non-infectious processes do not mutually exclude each 
other. Many pathogens such as bacteria or viruses encode for immune stimulating peptides, 
better known as superantigens for their enormous potency to stimulate immune cells 
(Kappler et al., 1989; Fleischer, 1991). T-cell superantigens have been developed twice 
during the evolution, namely independently by bacteria and by viruses. Not all bacteria or 
viruses do, however, possess a superantigen. - Superantigens act in a T-cell receptor V(beta) 
dependent manner (Figure 1). Thereby, up to 10% or even 20% of the T-cell repertoire may 
become activated, sometimes resulting in a fulminant inflammatory response. The latter 
depends also on the specific repertoire of the host’s antigen-detection apparatus, e.g., the 
human-leucocyte-antigen (HLA) molecules. 
 
 
Fig. 1. Antigen and superantigen recognition via the MHC/T-cell receptor complex. 
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Taken together, superantigens are expected to take part in the inflammatory events induced 
by their pathogenic source. In florid bacterial or viral encephalitis, the detrimental effects 
that may be attributed to the pathogen or to its superantigen may be hardly discerned, while 
both may contribute to the final outcome. However, in case of slowly progressing 
encephalitides of e.g. viral origin, the superantigenic stimulus might be responsible for the 
initial and leading symptoms while the consequences of viral degeneration could be 
compensated for for a considerable time period and may become symptomatic later during 
the disease course. This is what has been suggested to happen in multiple sclerosis (MS) 
(Kornhuber et al., 2002, Kornhuber 2006, Emmer et al., 2008, 2010). In this respect, it may be 
of significance that the initial events of MS plaque generation seem to develop in the absence 
of tissue inflammation (Filippi et al., 1998; Barnett and Prineas, 2004). Although the etiology 
for slow progression in MS remains to be established, it has been speculated on a possible 
role e.g. for human endogenous retroviruses such as MSRV (Garson et al., 1998; Perron and 
Lang, 2010; Antony et al., 2010). 
Our knowledge about the cerebral actions of T-cell superantigens, e.g. Staphylococcal 
enterotoxin A (SEA), relies on but a few experiments and, thus, is far from being 
comprehensive. Nevertheless, the results outlined below may be useful for future studies to 
further characterize the role of superantigens per se or in the context of bacterial or viral 
encephalitis, respectively. 
2. Effects of intracerebral T-cell superantigen 
Intracerebrally expressed superantigen induces a perivascular and periventricular 
inflammation (Kornhuber et al., 2002; Emmer et al., 2010). Fourty-microliter aliquots of 
superantigen or saline were slowly injected intracerebrally through a small burr hole in 
isoflurane-anesthetized male 300-g Lewis rats, 2.5 mm lateral from the midline at the 
bregma at a depth of 3.5 mm. Horizontal hematoxylin/eosin stained sections of the rat 
brains were investigated after fixing the brains with 4% buffered paraformaldehyde. 
Sections were obtained at the corpus callosum and at the level of the lateral ventricles. 
Cuffings of perivascular round cells were identified scattered around the injection canal. In 
the first 3 days, perivascular round cells could be observed in both hemispheres with a 
preponderance in the corpus callosum and the periventricular white matter. Thereafter 
perivascular round cells were confined to the injected hemisphere up to 12 days after SEA 
injection. Maximum response in the injected hemisphere was identified up to 8 days after 
injection (Fig. 1). 
We wondered why the response to superantigen was relatively variable and usually low. It 
is well known that relapses in MS are often precipitated by some nonspecific immune stress 
such as infection. Furthermore, it is known that only activated immune cells are capable to 
invade the CNS (Wekerle et al., 1986). For these reasons we tried to imitate the stress by 
loading the blood with activated immune cells. 
3. Activated splenocytes amplify superantigen encephalitis 
Activated syngeneic splenocytes were injected in volumes of 0.5 ml through the penis vein 
of 300 g male Lewis rats on the third day after intracerebral injection of the superantigen 
SEA (see above). Activation of splenocytes was achieved in the following way under sterile 
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conditions: A syngeneic spleen was cut and the content passed through a sieve into isotonic 
NaCl-solution. Cells were washed three times and the pellet finally resuspended in RPMI-
medium with 5 % heat-inactivated fetal calf serum and with a final concentration of 2 µg/ml 
concanavalin A (ConA). Cells were harvested and washed after 3 days in culture when they 
were maximally stimulated. They were kept in NaCl on crushed ice for injection purposes. 
Usually 107 cells were injected i.v. under brief general isoflurane anesthesia. The time course 
of the tissue reaction to 1 mg/ml SEA was investigated (Kornhuber et al., 2002). In general, 
perivascular round cell infiltrates were more numerous and more reproducible than without 
adding activated splenocytes. In the first up to 3 days after splenocyte injection, reactive 
vessels could be identified in both cerebral hemispheres with a preponderance on the 
injected side. Thereafter, inflamed blood vessels were confined to the injected hemisphere. 
The response was short-lived and could last for further 3 up to 12 days. Thereafter, no 
reactive vessels could be identified. On day 5 after i.v.-injection, on average 18.5±11.4 vessels 
with round cell cuffs were observed. When compared with the corresponding numbers 
obtained without i.v.-injection of activated splenocytes, the difference was statistically 
significant (p < 0.05; two-sided U-test). When the amount of activated splenocytes was kept 
constant at 107 per animal, the number of reactive blood vessels increased linearly with the 
concentration of SEA. When the injected SEA was kept constant at a concentration of 1 
mg/ml, the number of reactive blood vessels increased linearly with the number of 
intravenously injected activated splenocytes. 
4. Immunohistochemical characterization of round cell cuffing 
Immunohistochemical investigations of the SEA-encephalitis were performed using shock-
frozen brains fixed at -80 °C. Six µm kryocut sections were made at -14 °C. Neighboring 
tissue sections that showed both, the cerebral ventricles and the stitch canal were taken for 
further evaluation. The avidin–streptavidin–biotin (ABC)-method was used throughout for 
immunohistochemical staining purposes. All used antibodies were ordered by BD 
Biosciences Pharmingen. After preincubation with goat serum for 20 min, incubation with 
the primary antibody (1:50, 1 h) was followed by incubation with the secondary antibody 
(1:50, 30 min). After 30 min in the pre-diluted streptavidin–horseradish–peroxidase (HRP) 
all tissue sections were finally incubated with diaminobenzidine (DAB) solution until the 
desired colour intensity was obtained. Sections were dehydrated three times on increasing 
grades of alcohol and covered with Roti-Histokit. Spleen tissue slices served as the positive 
controls. All used primary antibodies were highly specific for their target antigen. Negative 
controls included substitution of primary antibodies by antibodies of the same isotype with 
specificities against non-host antigens.  
12 h after i.v. injection of ConA-activated spleen cells (i.e. 3 days after intracerebral injection 
of SEA), relatively high numbers of immunoreactive CD3+, CD4+ and CD8+ T-cells were 
present in a perivascular distribution and also scattered in the parenchyma around the stitch 
canal of the injected hemisphere (Fig. 3). The perivascular cuffs consisted of several layers of 
round cells. The amount of immunoreactive cells within the perivascular infiltrates, i.e. 
CD3+, CD4+ and CD8+ T-cells decreased gradually thereafter (Figs. 3 and 4) and amounted 
merely to usually 1 complete layer of immunopositive cells 3 days after i.v. injection of 
splenocytes and some loosely grouped perivascular cells after 5 days. Thus, the 
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inflammatory response was less large than in the previous experiments (see above). Among 
the different T-lymphocyte subsets, CD8+ T-cells were generally the most numerous ones 
(Figs. 3 and 4). The number of CD3+ T-cells within slices of the injected right hemisphere 
made up only about one quarter of the sum of the T-cells found to express CD8 or CD4 
(Figs. 3 and 4). The relative numbers of reactive blood vessels remained more or less 
constant within the investigated time period (not shown). In the non-injected left 
hemisphere, the inflammatory activity was generally less prominent (Fig. 4). In fact, notable 
numbers of CD4+ and CD8+ T-cells within perivascular cuffs were identified only 3 days 
after i.v. injection of ConA-activated spleen cells (Fig. 4). In the brains of control animals, T-
cells expressing CD4, CD8 or CD3 were not detected except for isolated immunopositive 
cells in the area of the stitch canal 0.5 days after the i.v. injection of ConA-activated 
splenocytes (not shown). Five days after the i.v. injection, no stained T-cells were found in 
the investigated brain slices of both control animals. 
The cerebral inflammatory reaction was short-lived, presumably due to the rapid 
disappearance of the injected superantigen, e.g. by non-specific binding to cell surfaces. 
Differences in the duration of the inflammation in the order of several days may be due to 
different preparations of the superantigen, which may impact the immunostimulatory 
potency of the SEA reagent.  
The cerebral inflammation induced by SEA was most prominent within the injected 
hemisphere and consisted initially mainly of CD8+ T-cells, which made up about 65% of the 
perivascular round cell population (Fig. 4). As no similar inflammatory response could be 
identified in the brains of the control animals that had received saline intracerebrally, the 
results do not appear to be due to the stitch trauma. Furthermore, only relatively small 
numbers of T-cells were found within the non-injected left hemisphere 0.5 days after i.v. 
injection of the ConA-activated splenocytes. As the number of the perivascular round cells 
detected in the left hemisphere peaked after 3 days following the i.v. injection of the ConA-
activated splenocytes (Fig. 4), migration from the injected right hemisphere via the corpus 
callosum is the presumable reason for their occurrence contralateral to the injection site as 
has been suspected previously (Kornhuber et al., 2002). How does the superantigen 
expressed in the brain tissue lead to local recruitment and activation of T-cells? Presumably, 
the unprocessed superantigen was presented by MHC molecules on the surface of 
perivascular cells, microglial cells or dendritic cells, which are known to express MHC-class 
II constitutively within the CNS (Sedgwick et al., 1993; Stoll, 2002). By way of contrast, 
MHC-class I is not present on cell surfaces in the cerebral parenchyma unless its expression 
is specifically induced (Sedgwick et al., 1993; Redwine et al., 2001). When the injected ConA-
activated cells appear in the circulation in high numbers after i.v. injection, namely 3 days 
after the intracerebral SEA-injection, free superantigen seems unlikely to be present in the 
cerebral extracellular fluid. Therefore, direct binding of SEA to the T-cell receptor (TCR) of 
ConA-activated splenocytes that come to traverse the blood–brain barrier does not seem to 
play a major role for T-cell activation in the present case (Fleischer, 1991; Herrmann et al., 
1990; Yagi et al., 1990). However, only relatively small numbers of T-cells migrate through 
the cerebral blood vessels as part of a surveillance process, unless specific stimuli force them 
to stay on the abluminal side (Wekerle et al., 1986). The persistence of T-cells within the 
parenchyma after intracerebral injection of SEA may be taken as evidence that a specific 
stimulus forced them to stay within the CNS, therefore. After local expression of SEA, the 
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majority of the T-cells detected within the intracerebral perivascular infiltrates was CD8+, 
while a minority was CD4+ (Figs. 1 and 2). Although superantigens presented via MHC II 
are well known to stimulate CD4+ T-cells, it has been demonstrated that SEA may activate 
CD8+ T-cells in a TCR-dependent manner (Müller-Alouf et al., 2001; Stinissen et al., 1995). 
Results obtained by gene expression analysis for the SEA encephalitis are in line with a 
CD8+ T-cell driven immune response (see below; Emmer et al., 2008). At a first glance it 
seemed to be curious that the numbers of T-cells expressing CD8 or CD4 detected within the 
right hemisphere in sum outnumbered the CD3+ ones at each investigated time point. The 
immunostaining for CD3 like that for CD4 and CD8 was of sufficient quality to allow a clear 
distinction between positive and negative cells (Fig. 3). Therefore, it does not seem likely 
that the mismatch between the results for CD3 and CD8 was artificial in nature. Actually, a 
diminished expression of CD3 but not of CD4 or CD8 has been reported previously for T-
cells that had been challenged by superantigen (Damle et al., 1993; Niedergang et al., 1995; 
Makida et al., 1996; Von Essen et al., 2004). Therefore, the finding of a lower expression of 
CD3 in comparison to CD8 on T-lymphocytes like in the present investigation can be taken 
as evidence for the presence of a previous superantigenic stimulus.  
Taken together, it has been demonstrated that the round cells that take part in perivascular 
cuffing of the encephalitis induced by the superantigen SEA are primarily composed of T-
cells, especially of CD8+ T-cells. This result may be of importance with respect to the 
pathogenesis of inflammatory diseases of the central nervous system. The fact that upon the 
superantigenic stimulus T-cells become CD3-negative in significant numbers, leaving the 
expression of e.g. CD8 unaltered, may be used to demonstrate the involvement of a 
superantigenic stimulus in different states of encephalitis. 
 
 
 
 
 
Fig. 2. The figure illustrates the effect of intracerebral superantigen. Frontal sections of the 
rat brain at the level of the corpus callosum, hematoxylin and eosin stain. The 
interhemispheric cleft has been marked by a star. (A) Five days after intracerebral SEA-
injection and 8 days after i.v. injection ConA-activated splenocytes. (B) Part A at a higher 
magnification. 
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Fig. 3. Representative immunohistochemical stains of rat brain slices of the right hemisphere 
(streptavidin–biotin-method) after intracerebral injection with Staphylococcal enterotoxin A 
(SEA). Slices obtained 0.5 and 3 days after i.v. injection of ConA-activated splenocytes show 
expression of the antigens CD8 (a, day 0.5; b, day 3), CD4 (c, day 0.5; d, day 3), and CD3 (e, 
day 0.5; f, day 3). Note the special preponderance of CD8+ T-cells (a) in comparison with 
CD4+ T-cells (c). With time, the perivascular round cell count decreased as exemplified by 
the T-cells expressing CD8, CD4 or CD3, 3 days after i.v. injection of ConA activated 
splenocytes (b, d, f) compared with those detected after 0.5 days (a, c, e) (Emmer et al.,  
2010). 
a b
c d
e f 
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Fig. 4. Summary of the perivascular round cell counts (columns) are given together with the 
standard deviation (bars) for the entirety of the cells per tissue slice and hemisphere (olive 
green) and for the cells positively stained with CD3 (blue), CD4 (green) and CD8 (red), after 
injection of the superantigen Staphylococcal enterotoxin A (SEA) into the right hemisphere 
followed by intravenous loading of ConA-activated splenocytes 3 days later. The bar of the 
first left-sided column has been cut. Its value amounts to 58 cells. The 3 investigated time 
points, i.e. 0.5 days, 3 days and 5 days, refer to the interval between intravenous splenocyte 
injection and sacrification of the animals (Emmer et al., 2010). 
5. Gene expression profile of superantigen encephalitis 
Of 5 male 300 g Lewis rats, two animals received 50 µl of 1 mg⁄ ml SEA and two animals 
were injected with saline into the right brain hemisphere during deep anaesthesia. Injections 
were placed 2.5 mm lateral to the midline and 2 mm behind the bregma. One rat was sham 
operated. Three days after this procedure, 1.5*107 ConA-activated splenocytes (see above), 
were injected into the penis vein of each animal. Eight days after the initial surgical 
procedure, brains were taken from all Lewis rats. A coronar disk (2 mm) including the 
injection channel was prepared and divided into an injected half and a non-injected half. 
The samples were snap frozen in isopropanol and stored at -80 °C. Microarray analysis was 
performed as described previously (Staege et al., 2004). Data analyses were performed by 
using Statistical Analysis of Microarrays (SAM) (Tusher et al., 2001). Results from the 4 rat 
brain hemispheres of the two ‘SEA’ animals were compared with the 4 hemispheres of the 2 
‘saline’ animals. Furthermore, the differential gene expression after saline injection versus 
sham operation was calculated. Due to the small sample size, a relatively conservative 
approach was followed with Δ = 0.75, a false discovery rate of 0.099 and a minimum change 
factor of three. To be acceptable, the signal intensities had to be above 30. Validation of 
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microarray data was done by real-time PCR. To validate the results of the microarray 
analysis, the transcriptional regulation of nine genes [CCL5 (RANTES), TIMP-1, 
osteopontin, CD74, RT1-Da, complement component 3, tenascin C, CD8 and CCL2 (MCP-1)] 
that showed significant differential expression in rat brains with SEA encephalitis was 
measured also using real-time PCR. Total RNA was extracted from brain tissue using Trizol 
(Invitrogen, Karlsruhe, Germany) or the RNeasy kit (Qiagen, Hilden, Germany). 
Quantitative RT-PCR (qRT-PCR) was performed by using the QuantiTect SYBR Green RT-
PCR Kit (Qiagen) using the following conditions: 94 °C, 45 s; 62 °C, 45 s; 72 °C, 60 s. Each 
reaction was subjected to melting temperature analysis to confirm presence of the expected 
products. Specific gene amplification was normalized to GAPDH. Target genes and GAPDH 
were amplified with 40 cycles using a ROTOR GENE RG-3000 (Corbett Research, Sydney, 
Australia) and ROTOR GENE 6 software. The threshold cycle (CT) value was defined as the 
fraction cycle number and set at 10 times the standard deviation above the mean baseline 
fluorescence calculated from cycles 3 to 15. The fold changes in the target genes normalized 
to actin 22 (as house keeping gene) and relative expression of controls (1 uninjected rat 
brain) was calculated by using standard ΔΔCT method.  
Of the 8800 investigated genes, 106 were at least 3-fold increased with SEA over saline, 
while 29 genes were decreased at least 3-fold. The respective microarray data of 
differentially overexpressed genes are summarized in Table 1. Genes with increased 
expression were grouped in the following order: antigen presentation, lymphocytes, 
chemokines ⁄ chemokine receptors, microglial reaction ⁄ macrophages, phagocytosis ⁄ 
opsonization, extracellular matrix ⁄ cell adhesion, anti-inflammatory reaction and 
miscellaneous/ compound to inflammation. Some of the genes with decreased expression 
(not shown) presumably belong to cerebral cell elements such as neurons or astrocytes, e.g. 
genes encoding for neurotransmitter receptors or ion channels. In fact, the expression for the 
genes encoding for CCL5 (RANTES), TIMP-1, osteopontin, CD74, RT1-Da, complement 
component 3, tenascin C, CD8 and CCL2 (MCP-1) in relation to the house keeping gene for 
actin 22 as measured by real-time PCR showed a high level of conformity in comparison 
with the results obtained by using microarrays. Differential gene expression after saline 
injection versus sham operation revealed at least 3-fold overexpression of six genes and 
underexpression of 40 genes (not shown). The relatively mild differences observed in the 
gene expression between both conditions may reflect the consequences of the injection 
trauma and are considered of minor relevance for the SEA encephalitis.  
When data were first analysed, it became obvious that after intracerebral SEA injection 
versus saline injection, expression of several genes was markedly increased in the injected 
hemisphere and also displayed considerable overexpression in the non-injected contralateral 
hemisphere as well. This finding might correspond to the bilateral perivascular 
inflammatory reaction observed by using histology in the first days of SEA encephalitis (see 
above). Due to this finding, it was decided to analyse both hemispheres together. This 
approach certainly reduces absolute values of differential gene expression and at the same 
time it might reduce detection of false-positive data, e.g. resulting from the small number of 
samples. The results are in conformity with the light microscopy findings of a perivascular 
inflammation.  
Among the genes with elevated expression, there was a considerable number of genes 
encoding for MHC class II molecules, which are constitutively expressed on microglial cells 
in the brain. In a state of encephalitis, they may be detected on astrocytes as well. 
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Superantigen is presented in the context of MHC class II. However, 8 days after 
intracerebral injection of the superantigen, it might be doubted whether the elevated 
expression of genes for MHC class II molecules is still a direct consequence of the 
superantigenic stimulus. Antigen-presenting cells present in the inflammatory area may 
comprise microglial elements, monocytes and astrocytes [elevated expression of genes for: 
Serping1, CD53 antigen, CCAAT⁄ enhancer binding protein (C ⁄ EBP) delta, glial fibrillary 
acidic protein (GFAP) and calcium binding protein S100A4]. T lymphocytes seem to play a 
major role among the hematogenous cellular infiltrates of the SEA encephalitis. While the 
genes for CD3 and CD8 were found to be significantly elevated, this was not the case with 
the gene for CD4. This fits to immunohistochemical results showing that the perivascular 
round cell cuffs are dominated by CD8+ T lymphocytes on days 3.5, 6 and 8 after 
intracerebral SEA injection (see above). This finding was unexpected as usually CD4+ T cells 
are activated by T-cell superantigen presented in the context of MHC class II molecules 
(Fields et al., 1996). By way of contrast, CD8+ T cells are predominantly stimulated in the 
context of MHC class I molecules (Jelonek et al., 1998). As the latter ones are not 
constitutively presented in the brain, it seems unlikely that these molecules play a major role 
in the induction of the SEA encephalitis. Rather SEA may have been presented in the context 
of MHC class II. Previously, a similar stimulation of CD8+ T cells via superantigen bound to 
MHC class II as found in the present investigation has been reported (Fraser, 1989). Of 
interest, there exists a parallel to MS, where CD8+ T cells have been reported to 
predominate among perivascular inflammatory infiltrates (Liu et al., 2007; Jilek et al., 2007). 
Further proteins involved in antigen presentation or in signalling cascades were 
significantly overexpressed with SEA comprise sialoprotein CD43, cathepsin C, and CD 72. 
Similar to other states of cerebral inflammation such as in MS or EAE, there was a profound 
increase in the expression of the genes for the following proteins involved in chemotaxis 
after SEA injection: RANTES (CCL5), osteopontin, MCP-1 (CCL2) and CXCL10. 
Furthermore, the gene for the receptor of MCP-1 (CCR2) showed a significantly increased 
expression. In contrast to the elevated chemokine levels, cytokines, such as interleukin-2, 
tumour necrosis factor alpha or interferon gamma, did not reveal significantly increased 
differential expression levels. As these cytokines belong to the group of substances which 
are released early in the course of an inflammation, it is quite plausible that the genes for 
these cytokines are not expressed any more differentially 8 days after injection of SEA. 
Intracerebral injection of SEA was followed by an enhanced expression of genes encoding 
different complement factors such as C3, C4a, C1q, B, D (adipsin) and serping 1. These 
factors may be released from microglial cells (Raivich and Banati, 2004) or from 
macrophages. Complement factors were suggested to play a role in opsonization and 
phagocytosis. Complement factors 1q, 3 and 4a showed a high expression in microarray 
studies in EAE and MS (Tajouri et al., 2003; Lock et al., 2002). Actually, increased expression 
was detected for genes that are also related to phagocytosis. These were Fc-gamma receptor, 
Vav1, galectin 3 (Wilkinson et al., 2006; Rotshenker, 2003). These genes were previously 
shown to display increased expression in EAE (Lock et al., 2002; Reichert and Rotshenker, 
1999; Carmody et al., 2006). A number of genes with increased expression levels after SEA 
injection were related to the extracellular matrix. These were lysyl oxidase, tenascin C, 
alpha-1- collagen type III, syndecan 1, alpha-1-collagen, alpha-1- procollagen type I, 
vimentin, matrix-gla-protein, periostin, oxidized LDL-receptor-1 and alpha-tubulin. The 
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gene for tenascin C was measured with elevated expression in EAE and in MS (Lock et al., 
2002, Carmody et al., 2006), while a similar increase for the gene of alpha-tubulin was 
present in MS (Carmody et al., 2006). Not all of the above summarized genes that showed 
enhanced expression after intracerebral superantigen injection did so in EAE or MS. 
Furthermore, the gene for integrin alpha M was detected with elevated expression in the 
present study. Integrin alpha M mediates cellular adhesion to the extracellular matrix 
(Friedl and Brocker, 2000). It is also upregulated in EAE and in MS (Lock et al., 2002, 
Carmody et al., 2006). Whether the enhanced gene expression of components of the 
extracellular matrix reflects alterations in the context of the encephalitis or reflects reparative 
activity remains to be established. Increased expression of the following genes may be 
regarded as part of an anti-inflammatory tissue reaction: alpha-2-macroglobulin, 
metallothionein, heat shock protein 27 (HSP27), haeme oxygenase-1, C⁄ EBP-related 
transcription factor beta, coeruloplasmin and pleckstrin. The gene products take part in the 
inactivation of proteolytic enzymes (alpha-macroglobulin), in the reduction in oxidative 
stress (methallothionein, haeme oxygenase 1, coeruloplasmin) or in the apoptosis induction 
(HSP27). Several of these genes have been observed with increased expression in EAE or in 
MS (Table 3), such as metallothionein (Tajouri et al., 2003; Lock et al., 2002; Penkowa and 
Hidalgo, 2003; Espejo et al., 2005; Espejo and Martinez-Caceres, 2005), haeme oxygenase 1 
(Levine and Chakrabarty, 2004; Tan et al., 2004) and HSP27 (Tajouri et al., 2003). 
Furthermore, there was a significant increase for the genes of the metalloproteinase 9 
(MMP9) and its inhibitor, the tissue inhibitor of metalloproteinase 1 (TIMP-1). Both genes 
were reported to be upregulated in EAE and in plaque tissue from patients with MS 
(Steinman, 1999; Pagenstecher et al., 1998). While MMP9 is e.g. required for the migration of 
lymphocytes through the basilar membrane and thus for invading the CNS, the much more 
pronounced upregulation of TIMP-1 may be regarded as an anti-inflammatory response. 
Other genes with increased expression levels in the SEA encephalitis are genes encoded for 
different cytochromes (P450 type 1b1, b558 and b245), granulin, lipocalin and STAT1. The 
role of the proteins during the course of the SEA encephalitis is not entirely clear. At least 
the elevated gene expression for STAT1 was noted previously in EAE (Jee et al., 2001) and in 
MS (Frisullo et al., 2006). Furthermore, the gene for granulin was observed with elevated 
expression in MS (Tajouri et al., 2003). 
Genes with decreased expression: The number of genes with significantly and at least 
threefold decreased expression was small (n = 29), in comparison with the number of genes 
showing an increased expression (n = 106). Among the former genes, there was a number of 
genes related to cerebral cellular functions such as neurotransmitter receptors, ion channel 
proteins, ion pumps or growth factor receptors: retinoid-X-receptor gamma, cholinergic 
receptor (nicotinic, alpha polypetide 2, neuronal), potassium voltage-gated channel, 
subfamily H member 8 (ATPase), proton pump (H+ transporting, V1 subunit G, isoform 3 
and H+⁄K+ ATPase), calbindin and oncomodulin. Expression of these genes was not 
observed to be decreased in EAE or MS. Nevertheless, in EAE and MS, genes with decreased 
expression levels were observed to encode proteins with similar functions. These included 
myosin VIIA, phosphatidylinositol 4- kinase (Tajouri et al., 2003), TGF beta 3, cadherin-7 
(Lindberg et al., 2004), somatostatin and kinesin (Lock et al., 2002). Taken together, the gene 
expression data in the present study support previously reported light microscopy findings 
of the encephalitis developing after superantigen injection into the rat brain (Kornhuber et 
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al., 2003). The peculiar gene expression pattern found 8 days after superantigen injection is 
compatible with a CD8+ T lymphocyte driven process leading to different cerebral 
inflammatory and anti-inflammatory reactions. As superantigens were implicated in the 
pathogenesis of human autoimmune diseases, such as MS, the comparison of the presented 
data with those gathered with EAE or MS may be of general interest. Actually, there is 
considerable conformity between the gene expression profile of the SEA encephalitis and 
EAE or MS (Table 2). This accordance between the three different states of inflammation 
may be due to the fact that a T-cell-driven pathogenesis is common to all of them. 
 
Accession no. Description SEA NaCl Ratio 
Antigen presentation
X13044  MHC-II (CD74 antigen)  3542  130  27.2 
X14254  MHC-II (invariant chain)  1209  45  26.9 
X07551  MHC-II B-alpha gene  1384  113  12.2 
X56596  MHC-II B-1 beta chain  1014  168  6.0 
X53054  MHC-II (protein complex)  1322  219  6.0 
M64795  MHC-I (CRT 1-u)  620 106 5.8 
U31599  MHC-II (DM beta)  433 82 5.3 
M36151  MHC-II A-beta gene (RT1 class II locus Bb)  794 154 5.2 
K02815  MHC-II (locus Ba)  1982 387 5.1 
M15562  MHC-II  1180  231  5.1 
X57523  TGF-beta (activated)  310 83 3.7 
AI171966  MHC-II (DM beta)  1619 440 3.7 
X67504  MHC-I (locus Aw2)  205 61 3.3 
U31599  MHC-II  215  69  3.1 
Lymphocytes 
X03015  CD8 antigen (alpha chain)  282  35  8.1 
S79711  CD3 gamma-chain  68  14  4.9 
X14319 T-cell receptor (beta chain)  282  61  4.6 
M10072 CD45 antigen  130  32  4.1 
U24441  Matrix metallopeptidase 9  198  49  4.0 
D90404  Cathepsin C  476  148  3.2 
AI045440 Sialophorin  75  24  3.1 
Chemokine ⁄ chemokine receptor
M14656 Secreted phosphoprotein 1 (osteopontin) 1694  94  18 
AI009658 CCL5 (RANTES) 1345  88  15.3 
AA892854 CXCL13 442  63  7 
X17053 CCL2 (MCP-1)  226  38  5.9 
AA945737 CXCR4  60  11  5.5 
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Accession no. Description SEA NaCl Ratio 
U17035 CXCL10 175  40  4.4 
X52498 TGF beta1 414  132  3.1 
Microglial reaction ⁄ macrophages
U18729 Cytochrome b558 alpha subunit 985  169  5.8 
U09540 Cytochrome P450 type 1b1 223  40  5.6 
AF028784 GFAP (alternatively spliced form) 4474  1030  4.3 
AI176856  Cytochrome P450 (Cyp1b1) 289  70  4.1 
AA800318 Serping1 1085  285  3.8 
M57276 CD53 antigen 537  158  3.4 
M65149 CCAAT ⁄ enhancer binding protein (C ⁄ EBP) 257  77  3.3 
M24067 Serpin E1 180  59  3.1 
U10894  Allograft inflammatory factor 1 669  219  3.1 
Phagocytosis ⁄ opsonization
J02962 IgE-binding protein (Galectin 3) 1220  87  14.0 
M29866 Complement component 3 1358 122  11.1 
X52477 Pre-pro-complement component 3  935  103  9.1 
X71127 Complement C1q beta chain 3632  649  5.6 
M92059 Adipsin 138  25 5.5 
X73371 Fc gamma-receptor 209  41  5.1 
AA892775 Lysozyme 4526  919  4.9 
AA891576 Complement component 1q 98  20  4.9 
AA893280 Adipose differentiation related protein 563  135  4.2 
AI639117 Complement factor B 268  65  4.1 
AI639117 Complement factor B 268  65  4.1 
M32062 Fc-gamma-receptor 3 433  117  3.7 
M32062 Fc gamma-receptor II beta 597  173  3.5 
U42719 Complement component 4a 1453  416  3.5 
D10757 Proteosome (macropain) subunit, beta type 9 277  80  3.5 
U39476 Vav 1 oncogene 106  31  3.4 
D88666 Fatty acid-binding protein (adipocyte) 131  40  3.3 
Extracellular matrix ⁄ cell adhesion
S66184 Lysyl-oxidase; fibroblast 140  16  8.8 
U15550 Tenascin-C 61  10  6.1 
S61865 Syndecan 1 105  20  5.3 
X70369 Collagen type III alpha 1 862  165  5.2 
U59801 Integrin alpha M 84  18  4.7 
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U75405UTR#1 Alpha-1 collagen mRNA 2804  624  4.5 
M27207 Procollagen, type 1, alpha 1 2070  568  3.6 
X62952 Vimentin 2652  763  3.5 
AI012030 Matrix Gla protein 1932  561  3.4 
AA894092 Periostin, osteoblast specific factor (predicted) 47  14  3.4 
AI231472 Procollagen, type 1, alpha 1 999  308  3.2 
AI071531 Oxidized low density lipoprotein receptor 1 63  20  3.2 
AA892333 Tubulin, alpha 6 1662  553  3.0 
Antiinflammatory reaction
AI169327 Tissue inhibitor of metalloproteinase 1  940  20  47.0 
M22670 Alpha-2-macroglobulin  219  9  24.3 
AI045030 CCAAT ⁄ enhancer binding protein  delta  118  22  5.4 
AA998683 Heat shock 27-kDa protein 1 1386  273  5.1 
AA817854 Ceruloplasmin  183  39  4.7 
AI169327 TIMP-1 1671  362  4.6 
S77528  NF-IL6 (C ⁄ EBP-related transcription factor beta) 74  16  4.6 
L33869  Ceruloplasmin  391  92  4.3 
AI176456 Metallothionein  11045  2980  3.7 
M86389  Heat shock 27-kDa protein 1  1563  444  3.5 
AA799323  Pleckstrin  99  29  3.4 
M65149  CCAAT ⁄ enhancer binding protein delta  257  77  3.3 
J02722  Haeme oxygenase (decycling) 1 194  58  3.3 
M23566  Alpha-2-macroglobulin 3153  989  3.2 
AA900582 Alpha-2-macroglobulin 1000  330 3.0 
 
Miscellaneous ⁄ compound to inflammation
L07114 Apolipoprotein B complex  378  23  16.4 
AA946503 Lipocalin 2  629  45  14.0 
M80367 Guanylate nucleotide binding protein 132  25  5.3 
X06916 Protein p9Ka, (S100 calcium binding Prot. A4)  774  153  5.1 
AA892553  STAT-1  261  54  4.8 
D26393 Hexokinase II  143  33  4.3 
X62322 Granulin  4118  1048  3.9 
AA946044  Yamaguchi sarcoma viral (v-yes-1) oncogene  79  21  3.8 
D21215 Coagulation factor 10  44  12  3.7 
AA894029  Cytochrome b-245 beta polypeptide) 116  31  3.7 
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L13192 Forkhead box D1  114  32  3.6 
M18349 Protein tyrosine phosphatase, receptor type, C  80  22  3.6 
J02869 Cytochrome P450 (Cyp2d9) 153  43  3.6 
S66024 CAMP responsive element modulator  68  19  3.6 
K03039  Leukocyte common antigen 35  10  3.5 
X61381 Interferon-induced trans-membrane protein 3  2347  671  3.5 
AI233219 Endothelial cell-specific molecule 1 38  11  3.5 
M33648 Coenzyme A synthase 2 192  56  3.4 
M19257 Retinol binding protein 1, cellular 653  199  3.3 
D30649 Ectonucleotide pyrophosphatase  3 56  17  3.3 
E00903 Natriuretic peptide precursor type A 362  112  3.2 
J05495 Macrophage galactose lectin 1 88  28  3.1 
S67722 Prostaglandin-endoperoxide synthase 2 595  192  3.1 
U77038 Protein tyrosine phosphatase type 6  68  22  3.1 
Table 1. Absolute and relative signal intensities measured with Affymetrix Rat Genome 
U34A are given for individual genes that exhibited significantly and at least 3-fold increased 
differential expression after intracerebral (i.c.) SEA injection compared with saline injection. 
 
Description    MS   EAE   SEA encephalitis 
 
MHC-II    ↑ [Lock et al., 2002]  ↑ [Carmody et al., 2006]  ↑ 
MHC-I     ↑ [Tajouri et al., 2003]     ↑ 
Matrixmetallopeptidase 9   ↑ [Steinman, 1999]     ↑ 
CD8 antigen alpha chain   ↑ [Liu et al., 2007]     ↑ 
T-cell receptor beta chain   ↑ [Lock et al., 2002] ↑ [Carmody et al., 2006]  ↑ 
CD3 gamma-chain   ↑ [Liu et al., 2007]    ↑ 
CD 45 antigen    ↑ [Liu et al., 2007]    ↑ 
Leukocyte common antigen  ↑ [Liu et al., 2007]    ↑ 
Cathepsin C (dipeptidyl    ↑ [Carmody et al., 2006]   ↑ 
peptidase I) 
Sialophorin (CD43)     ↑ [Ford et al., 2003]  ↑ 
Secreted phosphoprotein 1 ↑ [Lock et al., 2002] ↑ [Kim et al., 2004]  ↑ 
(osteopontin)    ↓ [Lindberg et al., 2004] 
Chemokine (C-C-motiv  ↑ [Boven et al., 2000]  ↑ [Dos Santos et al., 2005]  ↑ 
ligand) 5, RANTES 
Early response JE gene  ↑ [Tanuma et al., 2006]  ↑ [Hofmann et al., 2002]   ↑ 
(chemokine C-C motiv 
ligand 2 (MCP-1) 
Chemokine (C-X-C motif)   ↑ [Tajouri et al., 2003] ↑ [Tajouri et al., 2003]  ↑ 
ligand 10 (CXCL10) 
Transforming growth factor,  ↓ [Lindberg et al., 2004] ↑ [Carmody et al., 2006]  ↑ 
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beta 1 (TGF beta1)   ↑ [Lock et al., 2002] 
CD53 antigen      ↑ [Carmody et al., 2006]  ↑ 
IgE-binding protein    ↑ [Reichert, 1999]   ↑ 
(Galectin 3)    
Vav 1 oncogene      ↑ [Carmody et al., 2006]  ↑ 
Fc gamma-receptor   ↑ [Lock et al., 2002]    ↑ 
Lysozym    ↑ [Lock et al., 2002]    ↑ 
Complement C1q   ↑ [Tajouri et al., 2003]    ↑ 
Complement component 3  ↑ [Lock et al., 2002]    ↑ 
Complement component 4a    ↑ [Tajouri et al., 2003]  ↑ 
Fatty acid-binding protein    ↑ [Carmody et al., 2006]  ↑ 
(adipocyte) 
Integrin alpha M    ↑ [Lock et al., 2002] ↑ [Carmody et al., 2006]  ↑ 
Tenascin-C    ↑ [Lock et al., 2002] ↓ [Carmody et al., 2006]  ↑ 
Collagen type III alpha 1   ↓ [Tajouri et al., 2003] ↓ [Tajouri et al., 2003]  ↑ 
Tubulin, alpha 6    ↑ [Tajouri et al., 2003] ↓    ↑ 
Haeme oxygenase 1     ↑ [Tan et al., 2004]   ↑ 
TIMP-1       ↑ [Steinman, 1999]   ↑ 
Alpha 2 macroglobulin     ↑ [Hunter et al., 1991]   ↑ 
Heat shock 27-kDa protein 1    ↑ [Tajouri et al., 2003]  ↑ 
NF-IL6(C / EBP-related  ↑ [Lock et al., 2002]    ↑ 
transcription factor beta); 
Metallothionein    ↑ [Tajouri et al., 2003]  ↑ [Espejo et al., 2005]   ↑ 
GFAP (alternatively    ↑ [Tani et al., 1996]   ↑ 
spliced form) 
Granulin    ↑ [Tajouri et al., 2003]    ↑ 
STAT-1     ↑ [Frisullo et al., 2006]  ↑ [Carmody et al., 2006]   ↑ 
Coagulation factor 10     ↑ [Carmody et al., 2006]  ↑ 
Hexokinase II      ↑ [Carmody et al., 2006]  ↑ 
Protein tyrosine phosphatase,    ↑ [Carmody et al., 2006]  ↑ 
receptor type, C 
Guanylate nucleotide    ↑ [Carmody et al., 2006]  ↑ 
binding protein 
Table 2. Comparison of the differential expression of individual genes for which data were 
available for the SEA encephalitis (present investigation) and from EAE and MS.  
6. B-Cell superantigens and oligoclonal bands 
When the role of superantigens is considered with respect to encephalitis, B-cell 
superantigens have to be taken into consideration in addition T-cell superantigens. A 
prominent representative for B-cell superantigens is gp120, which forms part of the 
envelope of the human immune-deficiency virus (HIV) (Neshat et al., 2000; Patke and 
Shaerer, 2000; Zouali, 2007). Like T-cell superantigens, B-cell superantigens stimulate their 
target cells in a clonal manner (Müller and Köhler, 1997; Goodyear and Silverman, 2005). As 
more than 1 B-cell clone is expected to be stimulated by a B-cell superantigen, it may be 
speculated whether this type of stimulus would result in the presence of oligoclonal IgG 
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bands on isoelectric focussing. Indeed, oligoclonal IgG bands have been identified in various 
encephalitic diseases in the cerebrospinal fluid (CSF), including e.g. different forms of viral 
or bacterial encephalitis. Usually, all the antibodies forming oligoclonal bands in these 
diseases are directed against proteins of the encephalitogenic pathogen. However, there are 
states of encephalitis like in MS, where the presence of oligoclonal bands cannot be 
attributed to a certain pathogen. In fact, the antigen specificities present in MS oligoclonal 
bands comprise almost any antigen that has been tested. Therefore, these oligoclonal 
antibodies in MS have been termed as “nonsense antibodies” (Mattson et al., 1980). Among 
this nonsense-spectrum of antigen specificities, frequently an intrathecal antibody sythesis 
against measles, rubella, varizella zoster virus, herpes simplex virus, Epstein-Barr virus, and 
Chlamydia pneumoniae have been found (Reiber et al., 1998; Skorstad et al., 2009; Franciotta 
et al., 2010; Fainardi et al., 2009). It may be interesting to mention here, that antibodies 
specific for myelin proteins form only a small part of the oligoclonal IgG antibodies in MS 
(Owens et al., 2009). If nonsense antibodies like in MS would be due to a B-cell 
superantigenic stimulus, experimental proof should be available. Therefore, we tested in 
vitro, whether B-cell superantigens were capable to induce the formation of oligoclonal IgG 
bands on isoelectric focussing. In fact, after stimulation of peripheral blood mononuclear 
cells in vitro with the B-cell superantigen gp120, we detected IgG-bands by isoelectric 
focussing of the supernatant (Figure 5; Emmer et al., unpublished). This IgG-production   
 
 
Fig. 5. Representative results obtained by isoelectric focussing after stimulation of peripheral 
blood mononuclear cells from 3 healthy human donors in vitro with gp120 (8 µg/ml) and 
without gp120 (control). The numbers underneath the images denote the different subjects.  
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depended on the concentration of the B-cell superantigen. The detected oligoclonal bands 
were quite similar to those found by isoelectric focussing in the cerebrospinal fluid of MS- 
patients. Our results suggest that B-cell superantigens may play a role in the pathogenesis of 
the inflammatory response of multiple sclerosis. 
The expression of oligoclonal IgG in the CSF of MS-patients per se could have a detrimental 
influence, e.g. by opsonization of central nervous system components and subsequent 
phagocytosis by macrophages. In fact, the progress of the disease has been reported to be 
unfavourable if multiple oligoclonal bands are detected in the CSF of MS-patients (Joseph et 
al., 2009).  
7. Conclusion 
The present review focusses on the encephalitogenic effects of the intracerebrally expressed 
T-cell superantigen SEA. It has been demonstrated that SEA is capable to induce a 
perivascular inflammatory response, which was short lived after a single intracerebral 
injection. In the context of a pathogen residing within the CNS, a T cell superantigen is, 
however, expected to be expressed for prolonged periods of time and could, therefore, 
induce a longer lasting inflammatory response. The latter might add to the noxious response 
of the pathogen itself. Furthermore it was demonstrated that B-cell superantigens are able to 
stimulate B-cells to produce IgG which is detected as oligoclonal bands by isoelectric 
focussing. These oligoclonal bands resemble those found in the CSF of MS-patients.  
Beside bacterial infections, the presented findings could be of special relevance for viral 
encephalitis and possibly for multiple sclerosis.  
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